The Future of Breath Analysis

Over the past six years, Zurich Exhalomics has been at the forefront of research, technology development and clinical studies related to volatile biomarkers.

With the first Forum in 2022, we started a series to share and discuss perspectives on the future of breath analysis. The 2023 Zurich Exhalomics Forum attracted over 80 visitors from academia, industry and funding organisations who discussed new developments in the field.

The next Breath Forum will take place on September 27, 2024. Please reserve the date!

2024 Programme (preliminary)

09:30

Registration and coffee

10:00

Welcome and spotlight on Zurich Exhalomics

Prof. Dr. Emma Slack

10:30

Selected presentations from the Zürich Exhalomics Consortium

12:00

Lunch (Sandwiches, Fingerfood)

combined with the Poster Session

13:30

Keynote: "Clinical Applications of Exhaled Volatile Organic Compounds: from bench-to-bed"

Prof. Dr. Chris Mayhew, University of Innsbruck, Institute for Breath Research

14:30

Short presentations by industry

5 mins. each

15:00

Coffee Break and poster session

15:30

Selected presentations (consortium and guests)

‍

17:00

Farewell and apero

Prof. Dr. Renato Zenobi

Venue

Paulus Akademie
Pfingstweidstrasse 28, 8005 Zürich

Registration will open soon

Fees

Special rates for foundations and research institutions. Companies: CHF 250 per person, with sponsoring packages available.

Capacity

Maximum number of attendees: 100
Available Tickets: 40/100

Frequently asked questions

How can I contribute to the forum?

If you would like to present or contribute on stage or with a poster, please contact jan.vanbeilen@exhalomics.ch.
There is enough time for interaction during the sessions.

What's the language of the forum?

Primary language is English.

Who can I ask further questions?

Please contact Jan van Beilen (jan.vanbeilen@exhalomics.ch)

What is included in the participation fee?

All presentations, and catering from welcome coffee, lunch and apéro.

Why should I participate?

Getting access and share latest knowledge on breath analysis, from technology to clinical studies to commercial activities.